MitoTam iodide, hydriodide

Cat. No.: HY-126222A Purity: 98.57%: FAQs
Data Sheet SDS COA Handling Instructions

Molarity Calculator

MitoTam iodide, hydriodide is a Tamoxifen derivative, an electron transport chain (ETC) inhibitor, spreduces mitochondrial membrane potential in senescent cells and affects mitochondrial morphology. MitoTam iodide, hydriodide is an effective anticancer agent, suppresses respiratory complexes (CI-respiration) and disrupts respiratory supercomplexes (SCs) formation in breast cancer cells. MitoTam iodide, hydriodide causes apoptosis.

For research use only. We do not sell to patients.

MitoTam iodide, hydriodide Chemical Structure

CAS No. : 1634624-74-0

Size	Price	Stock	Quantity
5 mg	USD 500	In-stock	Estimated Time of Arrival: December 31
10 mg	USD 850	In-stock	Estimated Time of Arrival: December 31
25 mg	USD 1800	In-stock	Estimated Time of Arrival: December 31
50 mg	USD 3000	In-stock	Estimated Time of Arrival: December 31
100 mg	USD 4600	In-stock	Estimated Time of Arrival: December 31
200 mg		Get quote
500 mg		Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Other Forms of MitoTam iodide, hydriodide:

MitoTam bromide, hydrobromide In-stock

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description

MitoTam iodide, hydriodide is a Tamoxifen derivative^[1], an electron transport chain (ETC) inhibitor, spreduces mitochondrial membrane potential in senescent cells and affects mitochondrial morphology^[2]. MitoTam iodide, hydriodide is an effective anticancer agent, suppresses respiratory complexes (CI-respiration) and disrupts respiratory supercomplexes (SCs) formation in breast cancer cells^[1]^[2]. MitoTam iodide, hydriodide causes apoptosis^[2].

In Vitro

MitoTam (0.5 μM-56 μM; 24 hours) kills breast cancer cell Lines and nonmalignant cells with an IC₅₀ range from 0.65 μM to 55.9 μM^[1].
MitoTam (2.5 μM; 2-24 hours) results in stronger activation of the apoptotic pathway in MCF7 Her2^high cells compared with mock MCF7 cells^[1].
MitoTam (0.05 μM-1 μM; 3 days) causes a concentration-dependent induction of apoptosis in breast cancer cells, while there was no effect for non-malignant breast epithelial cells^[2].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay^[1]

Cell Line:	Breast Cancer Cell Lines: BT474, MCF7, MCF7 Her2^high, MCF7 Her2^low, MDA-MB-231, MDA-MB-436, MDA-MB-453, SK-BR-3, T47D; NeuTL cells; Nonmalignant Cells: A014578, H9c2 cells
Concentration:	0.5 μM-56 μM
Incubation Time:	24 hours
Result:	Killed breast cancer cells MCF7, MCF7 Her2^high, MCF7 Her2^low with IC₅₀ values of 1.25 μM, 0.65 μM and 1.45 μM respectively.

Western Blot Analysis^[2]

Cell Line:	MCF7 mock and MCF7 Her2^high cells
Concentration:	2.5 μM
Incubation Time:	2 hours, 4 hours, 8 hours, 16 hours, 24 hours
Result:	Revealed accelerated cleavage of procaspase-9, Parp1/2 and proapoptotic Bax and decreased the antiapoptotic Bcl-2 protein in Her2^high cells.

Apoptosis Analysis^[2]

Cell Line:	MCF-7, 4T1 and MCF-10a cells
Concentration:	0.05 μM-1 μM
Incubation Time:	3 days
Result:	Resulted in apoptosis in MCF7 and 4T1 cells.

In Vivo

MitoTam (intraperitoneal injection; 2 μg/g; once a week; 4 weeks) decreases β-gal staining of lungs from MitoTam-treated mice, accompaning by a inhibition in the expression of senescence markers p16^Ink4a, p21^waf1 and PAI comparing control mice ^[2].
MitoTam (intraperitoneal injection; 0.54 μmol/mouse; twice a week; 2 weeks) inhibits growth of syngeneic tumors by 80%^[1].
MitoTam (intraperitoneal injection; 0.25 μmol/mouse; twice a week; 2 weeks) slows down the growth of MCF7 mock tumors and stops tumor progression after two doses; suppresses Her2^high carcinomas decreased threefold from the original size with complete disappearance^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:	18-month-old or 2-month-old FVB/N mice^[1]
Dosage:	2 μg/g
Administration:	Intraperitoneal injection; 2 μg/g; once a week; 4 weeks
Result:	Eliminated senescent cells also in vivo.

Animal Model:	18-month-old or 2-month-old FVB/N mice^[2]
Dosage:	0.54 μmol/mouse
Administration:	Intraperitoneal injection; 0.54 μmol/mouse; twice a week; 2 weeks
Result:	Suppressed Her2^high breast carcinomas.

Animal Model:	18-month-old or 2-month-old FVB/N mice^[1]
Dosage:	0.25 μmol/mouse
Administration:	Intraperitoneal injection; 0.25 μmol/mouse; twice a week; 2 weeks
Result:	Prevented reaching the ethical endpoint in all situations, slowed down the growth of MCF7 mock tumors and suppressed Her2^high carcinomas decreased.

Molecular Weight

999.82

Formula

C₅₂H₆₀I₂NOP

CAS No.

1634624-74-0

Appearance

Solid

Color

White to light yellow

SMILES

CN(CCOC1=CC=C(/C(C2=CC=CC=C2)=C(C3=CC=CC=C3)/CCCCCCCCCC[P+](C4=CC=CC=C4)(C5=CC=CC=C5)C6=CC=CC=C6)C=C1)C.[H]I.[I-]

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, stored under nitrogen, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture)

Solvent & Solubility

In Vitro:

DMSO : 100 mg/mL (100.02 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	1.0002 mL	5.0009 mL	10.0018 mL
5 mM	0.2000 mL	1.0002 mL	2.0004 mL
10 mM	0.1000 mL	0.5001 mL	1.0002 mL

View the Complete Stock Solution Preparation Table

* Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (stored under nitrogen, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator
Dilution Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

This equation is commonly abbreviated as: C₁V₁ = C₂V₂

In Vivo Dissolution Calculator

Please enter the basic information of animal experiments:

Dosage

mg/kg

Animal weight
(per animal)

Dosing volume
(per animal)

μL

Number of animals

Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.

Calculation results:

Working solution concentration: mg/mL

Purity & Documentation

Purity: 98.83%

Select Batch:

Data Sheet (277 KB) SDS (252 KB)

COA (247 KB) HNMR (445 KB) LCMS (88 KB)

Handling Instructions (2659 KB)

References

[1]. Rohlenova K, et al. Selective Disruption of Respiratory Supercomplexes as a New Strategy to Suppress Her2highBreast Cancer. Antioxid Redox Signal. 2017 Jan 10;26(2):84-103. [Content Brief]

[2]. Hubackova S, et al. Selective elimination of senescent cells by mitochondrial targeting is regulated by ANT2. Cell Death Differ. 2019 Jan;26(2):276-290. [Content Brief]

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg

DMSO	1 mM	1.0002 mL	5.0009 mL	10.0018 mL	25.0045 mL
	5 mM	0.2000 mL	1.0002 mL	2.0004 mL	5.0009 mL
	10 mM	0.1000 mL	0.5001 mL	1.0002 mL	2.5005 mL
	15 mM	0.0667 mL	0.3334 mL	0.6668 mL	1.6670 mL
	20 mM	0.0500 mL	0.2500 mL	0.5001 mL	1.2502 mL
	25 mM	0.0400 mL	0.2000 mL	0.4001 mL	1.0002 mL
	30 mM	0.0333 mL	0.1667 mL	0.3334 mL	0.8335 mL
	40 mM	0.0250 mL	0.1250 mL	0.2500 mL	0.6251 mL
	50 mM	0.0200 mL	0.1000 mL	0.2000 mL	0.5001 mL
	60 mM	0.0167 mL	0.0833 mL	0.1667 mL	0.4167 mL
	80 mM	0.0125 mL	0.0625 mL	0.1250 mL	0.3126 mL
	100 mM	0.0100 mL	0.0500 mL	0.1000 mL	0.2500 mL